11 August 2021 - Impatient with years of inaction in Washington on prescription drug prices, U.S. hospital groups, start-ups and non-profits have started making their own medicines.
Impatient with years of inaction in Washington on prescription drug costs, U.S. hospital groups, startups and non-profits have started making their own medicines in a bid to combat stubbornly high prices and persistent shortages of drugs with little competition.